Managing intrathecal administration of nusinersen in adolescents and adults with 5q-spinal muscular atrophy and previous spinal surgery

Overview of attention for article published in Arquivos de Neuro-Psiquiatria, February 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 25 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

nusinersen

Cited by Canadian Agency for Drugs and Technologies in Health on 07 Nov 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.